Antimicrobial Susceptibility Testing - Why Monitoring and Trend Analysis Are Key episode artwork

EPISODE · Aug 7, 2020 · 8 MIN

Antimicrobial Susceptibility Testing - Why Monitoring and Trend Analysis Are Key

from CAPcast from the College of American Pathologists · host College of American Pathologists

Laboratories must report cumulative antimicrobial sensitivity information to the medical staff at least annually under accreditation requirements from both the CAP and the Joint Commission. Despite requirements to do this at the institutional level, there is no national reporting or convenient way for the institution to monitor trends or compare rates recorded by other laboratories, explains Dr. Ron Schifman in this CAPcast interview. The CAP is introducing a new Quality Management Tools program to help participating laboratories enhance the value of their cumulative antimicrobial susceptibility report. Dr. Schifman is currently emeritus Professor of Pathology at the University of Arizona and a member of the CAP Quality Practices Committee. He is one of the architects of this new quality management program involving antimicrobial susceptibility.

Episode metadata supplied by the publisher feed · Published Aug 7, 2020

Embed this episode

NOW PLAYING

Antimicrobial Susceptibility Testing - Why Monitoring and Trend Analysis Are Key

0:00 8:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CAPcast from the College of American Pathologists?

This episode is 8 minutes long.

When was this CAPcast from the College of American Pathologists episode published?

This episode was published on August 7, 2020.

Can I download this CAPcast from the College of American Pathologists episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!